AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Pseudomonas and Aminoglycosides: A Comparison
Pip Tengza: I think what happened with pseudo maybe arguably is even more controversial. The changes with Pseudomonas are more drastic and really clinicians need to know what's up with this, he says. "The take home from the M100 for 2023 from CLS side that will most blow people's minds," Pang added.